Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07733414) titled 'Evaluating the Efficacy and Safety of Daridorexant Transition From BZRAs in Insomnia Patients(EASY-TIP)' on July 24.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Xuanwu Hospital, Beijing

Condition: Insomnia Disorders

Intervention: Drug: Daridorexant

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: August 1, 2026

Target Sample Size: 156

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07733414

Disclaimer: Cur...